The Alistair Reid Venom Research Unit (ARVRU) of the Liverpool School of Tropical Medicine (LSTM) and MicroPharm Ltd. have a long association in the production and delivery of life-saving snake antivenoms for West Africa, which suffers the continent's highest snakebite mortality burden. Antivenom is the mainstay of snakebite treatment and is immunoglobulin purified from the sera of venom-immunised horses and sheep. There is a legal/regulatory requirement to conduct in vivo preclinical efficacy testing of new and existing antivenoms prior to human treatment. These assays carry a 'substantial' severity grading by the UK Home Office.
The objective of this PhD Studentship is to assess whether a cell-based system can be used to replace in vivo preclinical testing, and to determine the extent to which various 3R-modifications can be incorporated into these assays to reduce the numbers of animals and the associated pain, suffering and distress whilst retaining the scientific/regulatory validity of the assays.
Harrison RA et al. (2017). Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa. PLoS Negl Trop Dis 11(10). doi: 10.1371/journal.pntd.0005969
Herrera M et al. (2017). Freeze-dried EchiTAb+ICP antivenom formulated with sucrose is more resistant to thermal stress than the liquid formulation stabilized with sorbitol. Toxicon 133:123-126. doi: 10.1016/j.toxicon.2017.05.006
Pla D et al. (2017). What killed Karl Patterson Schmidt? Combined venom gland transcriptomic, venomic and antivenomic analysis of the South African green tree snake (the boomslang), Dispholidus typus. Biochimica et biophysica acta 1861(4):814-23. doi: 10.1016/j.bbagen.2017.01.020
Whiteley G et al. (2016). Stabilising the Integrity of Snake Venom mRNA Stored under Tropical Field Conditions Expands Research Horizons. PLoS Negl Trop Dis 10(6):e0004615. doi: 10.1371/journal.pntd.0004615
Gutiérrez JM et al. (2015). A Call for Incorporating Social Research in the Global Struggle against Snakebite. PLoS Negl Trop Dis 9(9):e0003960. doi: 10.1371/journal.pntd.0003960
Lecht S et al. (2015). Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki. Biochimica et biophysica acta 1850(6):1169-79.doi: 10.1016/j.bbagen.2015.02.002
Gutiérrez JM et al. (2014). A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming. Bulletin of the World Health Organization 92(7):526-32. doi: 10.2471/BLT.13.132431